THE MCMANUS GROUP for ZIMMER BIOMET
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Access and reimbursement of medical devices in Medicare program including in H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023, and S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024 Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC). H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAWREN D GEER | — |
| JOHN MCMANUS | — |
| ALEX WHALEN | — |
Health Issues HCR
Issues related to Artificial Intelligence approval in Medical Devices H.R.8818 - American privacy Rights Act of 2024
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAWREN D GEER | — |
| JOHN MCMANUS | — |
| ALEX WHALEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.